1. Home
  2. BRTX vs YQ Comparison

BRTX vs YQ Comparison

Compare BRTX & YQ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BRTX
  • YQ
  • Stock Information
  • Founded
  • BRTX 1997
  • YQ 2012
  • Country
  • BRTX United States
  • YQ China
  • Employees
  • BRTX N/A
  • YQ N/A
  • Industry
  • BRTX Managed Health Care
  • YQ Other Consumer Services
  • Sector
  • BRTX Health Care
  • YQ Real Estate
  • Exchange
  • BRTX Nasdaq
  • YQ Nasdaq
  • Market Cap
  • BRTX 11.3M
  • YQ 13.1M
  • IPO Year
  • BRTX N/A
  • YQ 2020
  • Fundamental
  • Price
  • BRTX $1.41
  • YQ $1.63
  • Analyst Decision
  • BRTX Strong Buy
  • YQ
  • Analyst Count
  • BRTX 1
  • YQ 0
  • Target Price
  • BRTX $18.00
  • YQ N/A
  • AVG Volume (30 Days)
  • BRTX 100.5K
  • YQ 42.7K
  • Earning Date
  • BRTX 11-12-2024
  • YQ 12-11-2024
  • Dividend Yield
  • BRTX N/A
  • YQ N/A
  • EPS Growth
  • BRTX N/A
  • YQ N/A
  • EPS
  • BRTX N/A
  • YQ N/A
  • Revenue
  • BRTX $377,000.00
  • YQ $28,507,378.00
  • Revenue This Year
  • BRTX $482.76
  • YQ N/A
  • Revenue Next Year
  • BRTX $212.24
  • YQ N/A
  • P/E Ratio
  • BRTX N/A
  • YQ N/A
  • Revenue Growth
  • BRTX 189.55
  • YQ 22.55
  • 52 Week Low
  • BRTX $1.03
  • YQ $1.47
  • 52 Week High
  • BRTX $3.67
  • YQ $3.55
  • Technical
  • Relative Strength Index (RSI)
  • BRTX 41.13
  • YQ 31.56
  • Support Level
  • BRTX $1.40
  • YQ $1.50
  • Resistance Level
  • BRTX $1.60
  • YQ $1.92
  • Average True Range (ATR)
  • BRTX 0.10
  • YQ 0.20
  • MACD
  • BRTX 0.00
  • YQ -0.01
  • Stochastic Oscillator
  • BRTX 42.86
  • YQ 16.13

About BRTX BioRestorative Therapies Inc. (NV)

BioRestorative Therapies Inc is a biotechnology company based in the United States. It focuses on the development of regenerative medicine products and therapies using cell and tissue protocols, primarily involving adult (non-embryonic) stem cells. The company's two core development programs include the Disc/Spine Program, which involves cell therapy candidate, BRTX-100, a product formulated from autologous cultured mesenchymal stem cells collected from the patient's bone marrow; and the Metabolic Program, which includes the development of cell-based therapy to target obesity and metabolic disorders using brown adipose-derived stem cells, to generate brown adipose tissue.

About YQ 17 Education & Technology Group Inc.

17 Education & Technology Group Inc is an education technology company in China. It offers to assist students, teachers, schoolmasters, and educational authorities across China to achieve data-driven teaching, learning, and assessment. Geographically group operates in China.

Share on Social Networks: